Record 2014 earnings reported the leading pharmaceutical distributor Sopharma Trading, ELANA Trading analysts say in their new earnings report on the company listed on the Bulgarian Stock Exchange. Net sales surged 13.6% y-o-y to BGN 576 m outpacing the whole pharmaceutical market, which grew by 8% y-o-y.

Analysts report that main growth drivers of Sopharma Trading were portfolio diversification and better performing hospital segment (17% increase y-o-y) where the company is the market leader. Growing pharmacy segment (7% y-o-y) also added to the excellent performance thus pushing the company’s overall market share to 23% – 39% of the hospital segment and 19% on the pharmacy segment.

Sopharma Trading is part of the Sopharma group that integrates one of the leading generic and organic pharmaceutical producer in the country – Sopharma (3JR BU), together with other supporting operations.

One of the liquid shares on the Bulgarian stock market, Sopharma Trading stocks went up 17.5% in the last 12 months (March 2015 – 2014) to BGN 5.29 per share (gross dividend of BGN 0.23 not included).

2014 Corporate earnings report on Sopharma Trading by ELANA Trading analysts